SEC Form 4 · accession 0001437749-16-037066
Protagenic Therapeutics, Inc.\new · PTIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Khalil Barrage
Director
Period of report
Aug 8, 2016
Accepted (ET)
Aug 10, 2016 · 7:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| NSO Stock OptionF1,F2 | Aug 8, 2016 | A | 150,000 | $1.25 | A | 245,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Price indicated refers to exercise price per share of the option grant
- F2A previous Form 4 regarding a transaction on June 17, 2016 erroneously indicated that Mr. Barrage beneficially owned 245,000 shares worth of equity securities following the reported transactions on that day. The correct figure would have been 95,000 shares worth of equity securities. 245,000 shares is the correct figure following the current 150,000 option grant.